Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Over $13M Bet On This Energy Stock? Check Out These 4 Stocks Insiders Are Buying

Published 10/11/2023, 13:52
Updated 10/11/2023, 15:10
© Reuters.  Over $13M Bet On This Energy Stock? Check Out These 4 Stocks Insiders Are Buying

Benzinga - by Lisa Levin, Benzinga Editor.

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Aura Biosciences

  • The Trade: Aura Biosciences, Inc. (NASDAQ: AURA) 10% owner David Goel acquired a total of 1,560,000 shares an average price of $9.00. To acquire these shares, it cost around $14.04 million. The company’s Director also bought 199,601 shares.
  • What’s Happening: Aura Biosciences posted a narrower-than-expected loss for the third quarter.
  • What Aura Biosciences Does: Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
  • Mastercard
  • The Trade: Mastercard Incorporated (NYSE: MA) Director Richard K Davis acquired a total of 1,000 shares at an average price of $390.96. To acquire these shares, it cost around $390,960.
  • What’s Happening: Mastercard reported better-than-expected earnings for its third quarter.
  • What Mastercard Does: Mastercard is the second-largest payment processor in the world, having processed close to over $8 trillion in transactions during 2022.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

STAAR Surgical

  • The Trade: STAAR Surgical Company (NASDAQ: STAA) 10% owner Broadwood Capital Inc bought a total of 289,140 shares at an average price of $33.42. To acquire these shares, it cost around $9.66 million.
  • What’s Happening: Staar Surgical reported better-than-expected earnings for its third quarter.
  • What STAAR Surgical Does: Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye.
Energy Transfer
  • The Trade: Energy Transfer LP (NYSE: ET) Executive Chairman Kelcy Warren bought a total of 1,000,000 shares at an average price of $13.33. The insider spent around $13.33 million to buy those shares. The company’s EVP also bought 10,000 shares.
  • What’s Happening: Energy Transfer posted downbeat earnings for the third quarter.
  • What Energy Transfer Does: Energy Transfer owns a large platform of crude oil, natural gas, and natural gas liquid assets primarily in Texas and the U.S. midcontinent region.

Check This Out: Top 2 Materials Stocks You May Want To Dump This Quarter

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.